Disease burden, diagnosis pathways and treatment patterns in patients with eosinophilic esophagitis: a real-world study
Patients with EoE experience a substantial disease burden, with a significant delay in diagnosis. Achieving optimal disease control remains an unmet need with conventional nonbiologic therapies.
Authors
- Felio Bello (ORCID: https://orcid.org/0000-0003-1459-0278)
- Ryan B. Thomas (ORCID: https://orcid.org/0000-0002-1141-2073)
- Frank Zerbib
- Rohan Parikh (ORCID: https://orcid.org/0000-0003-4516-9996)
- Juby A. Jacob‐Nara (ORCID: https://orcid.org/0000-0002-5372-8762)
- Sarette T. Tilton
- Amr Radwan (ORCID: https://orcid.org/0000-0002-5567-6708)
- Christopher Ma (ORCID: https://orcid.org/0000-0002-4698-9948)
- Kinga Borsos
- Tiffany Pela
- Ulrike von
Institutions
- Université de Bordeaux (FR)
- University of Calgary (CA)
- Regeneron (United States) (US)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Sanofi (United States) (US)
- RTI Health Solutions (US)
- Hôpital Cardiologique du Haut-Lévêque (FR)
- University Hospital Magdeburg (DE)
Publication Details
- Journal
- European Journal of Gastroenterology & Hepatology
- Published
- 2025-07-25
- DOI
- https://doi.org/10.1097/meg.0000000000003049
- Primary Topic
- Eosinophilic Esophagitis
- Type
- article
- Field-Weighted Citation Impact
- 0.00